CONTINENTAL STRATEGY, LLC

Lobbying for NRX PHARMACEUTICALS · Clinical biopharma company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · $75,000.00 income · posted Apr 18, 2026

Lobbying activity 1

Pharmacy

Issues regarding lifesaving treatments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem